Product correctly added to cart.

discount label
Montelukast dicarboxylic acid
View 3D

Biosynth logo

Montelukast dicarboxylic acid

CAS: 213380-27-9

Ref. 3D-NIA38027

1mgTo inquire
5mgTo inquire
10mgTo inquire
25mgTo inquire
Estimated delivery in United States, on Friday 12 Jul 2024

Product Information

Name:
Montelukast dicarboxylic acid
Description:

Montelukast is a drug product that belongs to the class of drugs called leukotriene receptor antagonists. Montelukast binds to cysteinyl leukotrienes (LTC4, LTD4, LTE4) and prevents their interaction with receptors on the cell surface. It can be used for the treatment of asthma, chronic obstructive pulmonary disease, and other allergic conditions. Montelukast is available in tablet form and is taken orally. Montelukast is not expected to be toxic because it has been shown to have a low incidence of side effects in clinical trials.

Montelukast dicarboxylic acid (CAS No. 213380-27-9) is an impurity standard for HPLC analysis of montelukast products. It is a synthetic compound that has been custom synthesized for use as an impurity standard in order to meet the pharmacopoeia's requirements for purity and stability in pharmaceuticals

Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
616.20 g/mol
Formula:
C35H34ClNO5S
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-NIA38027 Montelukast dicarboxylic acid

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".